MedSmart Group Inc (MSGP)

[balamidas]

HUGE find $$$$$$MUST READ all$$$$$


from june 21 PR :In June 2009 the company obtained all rights to the GlynnTech, Inc. cancer drug delivery system, at cost. This includes one issued patent (US No. 7,637,889 B2), one pending application, three years of development work, a prototype, numerous CAD drawings of various embodiments, risk analysis and development pre-FDA filing history. Ken had three meetings with a major pharma company who expressed serious interest and has indicated that a contract will likely be offered for acquisition of the intellectual property after FDA filings have been made, but before FDA approval. If successful, a seven figure payment would be expected



and then come the 6 july PR :

Ken also announced that the first patent application on biodegradable bandages will be filed before July 12, 2010, that the second will be filed by July 30, 2010 and that the joint application with Dr. Alain Martin, (the inventor of Neosporin and other commercially successful products) will be filed shortly thereafter


then Sterling DD post :

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52784154


then I come :)


Dr Alain Martin is the CEO of North Cell Pharmaceutical


http://www.northcellpharma.com/

http://www.northcellpharma.com/aboutus2.html

North Cell Pharmaceutical has developed a technology platform of patented ingredients (Skin Resuscitation Factor™ SRF™) that can down regulate inflammation (eliminate the destruction of nitric oxide to peroxynitrite), to enhance healing or to up regulate nitric oxide that can be used by the human body to kill bacterial, viral, and fungal infections and tumors. SRF™ can be used independently to create new products or can be added to existing products to enhance efficacy and to generate new product claims.

North Cell and GlaxoSmithKline Sign Agreement
North Cell Pharmaceutical, Inc. and GlaxoSmithKline Consumer Healthcare have entered into an Option and Development Agreement regarding North Cell’s Skin Resuscitation FactorTM (SRFTM ) technology for use in certain applications. . .

North Cell Granted New Patent On
Anti-Cancer Compound
Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer

so now we have an idea what BIG announcement is pending here and HUGE seven figures payment

SSWC is going to run wild